CJC-1295 + Ipamorelin · Molecular Targets
Molecular Targets
The molecular targets below are the interaction points most frequently cited when CJC-1295 + Ipamorelin (CJC-1295 No DAC + Ipamorelin) is discussed in mechanistic research. Each is described at the level of cell biology (what the target is and why it is studied), not as an effect produced in any organism. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Reported targets at a glance
CJC-1295 + Ipamorelin is a paired research peptides associated in the literature with GHRH receptor (CJC-1295) and ghrelin / GHS-R1a receptor (Ipamorelin).
These associations come from in-vitro and preclinical studies. The dominant target can differ between model systems, so the list reflects the breadth of what has been investigated rather than a single confirmed pathway.
- Primary target
- GHRH receptor (CJC-1295)
- Target 2
- ghrelin / GHS-R1a receptor (Ipamorelin)
What these pathways are
In cell biology, targets like GHRH receptor (CJC-1295) and ghrelin / GHS-R1a receptor (Ipamorelin) are signaling nodes: receptors or enzymes that, when engaged, alter downstream molecular activity in a cell. Researchers use compounds such as CJC-1295 + Ipamorelin as tools to probe how those nodes behave in a controlled model.
Because CJC-1295 + Ipamorelin is supplied as paired compounds, studies may examine each component's target separately or the combined signaling of both, a common design in this area of research.
Why the target matters to researchers
A defined molecular target makes a compound useful for asking precise questions: does engaging this receptor change a measurable molecular readout in this assay? That is the kind of question CJC-1295 + Ipamorelin is used to investigate.
None of this implies a health effect. Target-level findings are observations about molecular systems and are not evidence of benefit or safety in people. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Available from Blueprint Labs
CJC 1295 No DAC + IPA 10mg
Third-party tested, CJC-1295 + Ipamorelin supplied as a research material with a certificate of analysis available.
Questions, answered
What does CJC-1295 + Ipamorelin target?
Published research associates CJC-1295 + Ipamorelin with GHRH receptor (CJC-1295) and ghrelin / GHS-R1a receptor (Ipamorelin). These are molecular targets studied in laboratory models, not effects in humans.
Is CJC-1295 + Ipamorelin selective for one receptor?
The literature reports more than one associated target for CJC-1295 + Ipamorelin (GHRH receptor (CJC-1295) and ghrelin / GHS-R1a receptor (Ipamorelin)), so it is generally described as acting across multiple sites rather than being strictly selective.
Does engaging these targets produce a health benefit?
No such claim is made here. Target engagement is a molecular observation in research models. For research use only. Not for human consumption, diagnostic, or therapeutic use.